Purpose: To investigate early visual and refractive outcomes, corneal stability and optical quality after femtosecond laser small-incision lenticule extraction (SMILE) for treating myopia and myopic astigmatism over À10 D. Methods: Thirty eyes (30 patients) with myopia and myopic astigmatism of over À10 D were treated with VisuMax â femtosecond laser (version 3.0; Carl Zeiss Meditec AG, Jena, Germany). Six months postoperative safety, efficacy and predictability were evaluated. Corneal Scheimpflug topography was measured preoperatively, 1 day, 3 months and 6 months postoperatively. Wavefront aberrations were measured preoperatively, 3 months and 6 months postoperatively. Results: Six months postoperatively, LogMAR uncorrected and corrected distance visual acuity (CDVA) were À0.013 AE 0.086 and À0.073 AE 0.069, respectively. 73% (97%) of eyes were within 0.5 (1) D of target refraction. No eyes lost CDVA, 43% (13 eyes) gained one line and 7% (two eyes) gained two lines. Mean corneal back curvature (KMB) and posterior central elevation (PCE) did not change significantly comparing preoperative and 6 months postoperative data (p = 0.91 and 0.77, respectively). Comparing 1 day with 6 months postoperative data, central corneal thickness (CCT), mean corneal front curvature (KMF), KMB and PCE did not change significantly (p = 0.27, 0.07, 0.52, 0.71, respectively). Total higher-order aberration (HOA), spherical aberration and coma increased significantly (p < 0.01) but trefoil remained stable (p = 0.49). Conclusion: Our results indicate that SMILE can correct myopia and myopic astigmatism of over À10 D predictably. No early ectasia was observed. Long-term changes in visual quality and corneal stability require further investigation.
Introduction
Laser refractive surgery has been widely performed for the correction of refractive errors throughout the world. Among all types of refractive surgeries, femtosecond laser SMILE is a relatively new surgical technique which leaves no corneal flap but cuts a stromal lens, called lenticule, which is extracted through a small side cut (Sekundo et al. 2008 (Sekundo et al. , 2011 Shah et al. 2011 ). This new surgery was shown to provide good surgical outcomes in terms of safety, efficacy, predictability and stability (Sekundo et al. 2008; Kamiya et al. 2014; Vestergaard et al. 2014 ). However, due to software limitation of the VisuMax femtosecond laser system, total correction of myopia and myopic astigmatism is restricted to 10 D. A recently released software made treatments over À10 D possible and may have the potential to extend the surgical indications of the SMILE procedure.
In this study, we performed SMILE on patients with myopia and myopic astigmatism of over À10 D. The purpose of this study was to evaluate early visual and refractive outcomes of SMILE for treating myopic astigmatism over À10 D and to analyse safety, efficacy, predictability and corneal stability of the procedure at an early stage postoperatively.
Patients and Methods
This study adhered to the tenets of the Declaration of Helsinki and was approved by the Ethics Committee of the Eye and ENT Hospital, Fudan University, China. All patients signed their informed consent after a detailed explanation of the risks and potential outcomes of refractive surgery and the study.
Thirty patients (30 eyes) were enrolled in this prospective study. One eye in each patient was randomly selected. All patients underwent routine preoperative examinations and met the surgical indications for SMILE. The SMILE procedures were conducted in the Refractive Surgery Center of the Department of Ophthalmology, Eye and ENT Hospital of Fudan University (Shanghai, People's Republic of China) from October 2015 to March 2016. Inclusion criteria were age 18-40 years, spherical myopia over À8 D and sum of spherical refraction and astigmatism ≥À10 D, CDVA 20/30 or better and stable refractive error (≤0.50 D of refractive error change in the past 2 years). Exclusion criteria were a history of other ocular conditions except myopia with or without astigmatism, suspicion of keratectasia as determined by the Ambrosio-Belin module of the Pentacam Ò (Oculus Ltd., Wetzlar, Germany), a history of ocular surgeries or trauma and any chronic systemic disease. Eyes with a calculated postoperative residual stromal bed of less than 250 lm were excluded. Patients with pregnancy or breastfeeding were also excluded. Patient data are shown in Table 1 .
We determined manifest refraction, visual acuity (VA), intra-ocular pressure (Tonoref II, Nidek, Japan) and pupil size (Nidek pupillometer) and performed a slit lamp examination and fundoscopy. In addition, Pentacam Ò Scheimpflug imaging was performed preoperatively, 1 day, 3 months and 6 months postoperatively. Central corneal thickness (CCT), KMF, KMB and PCE were evaluated. Mean corneal front curvature (KMF)/KMB is defined as mean corneal front/back curvature of the central 4-mm zone. The DPCE was defined by subtracting preoperative PCE data from postoperative PCE data to ensure measuring the same point at different observation time on the elevation maps. Residual bed thickness was calculated by subtracting cap thickness and ablation depth from preoperative thinnest corneal thickness obtained from Pentacam Ò measurements. Only eyes with a calculated postoperative residual stromal bed of more than 250 lm were included. Patients had to discontinue wearing contact lenses for at least 7 days (soft lenses) or 1 month (hard lenses) before the assessment. Wavefront aberrations were measured with the WASCA Analyzer (Carl Zeiss, Meditec, Jena, Germany) under standardized scotopic light settings. All data were checked to ensure that all eyes had a pupil of 5.0 mm or larger during measurement. Total eye wavefront error root-mean-square (RMS) values of total HOA, spherical aberration, coma and trefoil were calculated at 5-mm pupil size using Zernike polynomials.
Surgical technique
The surgical technique has been previously described (Miao et al. 2014; Luo et al. 2015) . Small-incision lenticule extraction (SMILE) was performed by the same experienced surgeon (XZ) using the VISUMAX Ò femtosecond laser system (version 3.0; Carl Zeiss Meditec AG). This version of software is modified for clinical study only, with spherical correction up to À14 D and astigmatism correction up to 5 D. Femtosecond scanning was performed with a repetition rate of 500 kHz and a pulse energy of 130 nJ using 4.5 lm spot/track distance on lenticule and cap, 2 lm spot/track distance on lenticule side and cap side. The intended cap thickness was set to 110 or 120 lm in all cases. The width of the side cut was set to 2 mm at 90°( 12-o'clock position). The intended diameter of the lenticule (optical zone) was set to 6.0-6.4 mm to keep the residual bed thickness within safety limitation while minimize the risk of postoperative glare. The diameter of the cap was set to 1 mm larger than the diameter of the lenticule. A 0.25-0.75 D overcorrection was added to the target correction according to preoperative manifest refraction and age in all eyes based on the surgeon's experience to compensate regression. The lenticule was subsequently dissected with a micro-spatula and removed. All procedures were completed successfully, and no intra-operative or postoperative complications were observed. Postoperative medications included 0.3% tobramycin for 1 week, 0.1% fluorometholone for 1 months and artificial tears for 2-3 months.
Statistical analysis
All data were collected on standardized study spreadsheets and entered into Excel 2011 (Microsoft, Inc., Redmond, WA, USA) for further statistical analysis. Statistical analyses were performed using SPSS version 19.0 (SPSS, Inc., Chicago, IL, USA). Statistical analysis for VA was based on logMAR units. A random eye of each patient was calculated by picking a random number from 0 to 1 for each eye, and the eye having larger number was enrolled in this study. For repeated measurements, the paired Student's t-test was used for normally distributed data and the Wilcoxon signed-rank test for abnormal distributed data. The ShapiroWilk test was used to test for normality. A p value <0.05 was considered statistically significant. Standardized graphs and terms for refractive surgery results were used in accordance with the recommendations. CCT = central corneal thickness, CDVA = corrected distance visual acuity, D = dioptres, LogMAR = logarithm of the minimal angle of resolution, SD = standard deviation.
Results

Safety and efficacy
All surgeries were completed without intra-operative or postoperative complications. No case of keratectasia was observed in our study. No eyes were lost during the 6 months follow-up. Six months postoperatively, logMAR uncorrected distance visual acuity (UDVA) and CDVA were À0.013 AE 0.086 and À0.073 AE 0.069, respectively. Seventy-seven percent of eyes had postoperative UDVA of 20/20 or better (Fig. 1) . As shown in Fig. 2 , 22 eyes (73%) had postoperative UDVA same or better than preoperative CDVA. Fifteen eyes (50%) showed no change in CDVA, 13 eyes (43%) gained one line, and two eyes (7%) gained two lines (Fig. 3) . The safety index (ratio between CDVA at 6 months and preoperatively) was 1.14 AE 0.17 (range, 0.88-1.67). The efficacy index (ratio between UDVA at 6 months and preoperative CDVA) was 1.02 AE 0.18 (range, 0.67-1.33).
Predictability and stability
A scatter plot of the attempted versus the achieved spherical equivalent (SEQ) correction is shown in Fig. 4 . Six months postoperatively, 73% of eyes were within AE0.5 D and 97% of eyes were within AE1.0 D of the attempted correction (Fig. 5 ). As shown in Fig. 6 , 6.67% of eyes (two of 30 eyes) had SEQ refraction change more than 0.5 D comparing postoperative 3 and 6 months.
Scheimpflug imaging corneal stability
As shown in Table 2 , there was no statistical difference comparing CCT, KMF, KMB, PCE and DPCE between postoperative 1 day and 6 months (p = 0.27, 0.07, 0.52, 0.71, 0.71, respectively). Comparing preoperative with postoperative 6 months data, CCT and KMF were significantly decreased (p < 0.01) but there was no statistical difference comparing KMB and PCE (p = 0.91, 0.77, respectively).
Higher-order aberrations
Comparing preoperative with postoperative 6 months aberrations, HOA RMS, spherical aberration and coma significantly increased (p < 0.01). Trefoil remained stable comparing preoperative data with postoperative 6 months data (p = 0.49). There was no statistic difference comparing postoperative 3 months with 6 months data (Table 3) .
Discussion
Small-incision lenticule extraction (SMILE) is widely accepted in the treatment of low-to-moderate myopia and myopic astigmatism. Many studies comparing surgical results of SMILE with those of femtosecond laserassisted LASIK have shown similar results regarding safety, efficacy, predictability and stability (Ang et al. 2015) .
In our pilot study, we evaluated the use of SMILE in high myopia or myopic astigmatism (more than À10 D) using a new software designed to treat these eyes. The surgical procedure was identical, and no intra-operative or postoperative complications were observed. Comparing safety, previous results of SMILE up to À10 D of SEQ have shown safety indices of 1.01 AE 0.05 (Lin et al. 2014 ) at 3 months and 1.09 at 1 month, which was similar to our results of 1.14 AE 0.17 for extreme myopia. Several studies have reported that 1.1% (Sekundo et al. 2011 ), 1.67% (Lin et al. 2014 ) and 2.3% ) of the treated eyes have lost one or more line of CDVA during a 3 months or 6 months investigation period. In our study, no loss of lines occurred, but 43% gained one line and 7% gained two lines. A possible explanation is the increase in magnification as preoperative VA was tested with spectacle correction. Comparing efficacy, previous studies of SMILE up to À10 D have shown efficacy indices of 1.04 AE 0.20 (Lin et al. 2014 ) at 3 months and 1.09 at 1 month. Our 6 months result of 1.02 AE 0.18 in myopia over À10 D is consistent with these results. For SMILE up to À10 D, 62% of eyes had an UDVA of 20/20, and 93% of 20/ 40 or more Zhao et al. 2013; Kamiya et al. 2014 ). In our study, 77% of eyes had an UDVA equal to or more than 20/20, and 100% of 20/40 or more (Fig. 1 ). For predictability, other studies of SMILE in high myopia (preoperative SEQ of ≥6.00 D) reported a predictability of 80% ) and 88% (Vestergaard et al. 2014) within AE0.50 D of target refraction, and of 94% ) and 97% (Vestergaard et al. 2014) within AE1.0 D, respectively. These results were consistent with our findings of 73% within AE0.50 D and 97% within AE1.0 D (Fig. 5) . In terms of stability, Sekundo et al. (2014) and Kamiya et al. (2015) reported a 4% and 0% of eyes with refractive regression of more than 0.5 D 1 year after conventional SMILE procedure, respectively. Our 6 months observation showed a regression rate (two of 30 eyes) of 6.67%, while 93.3% of eyes showed no significant regression. Previous studies comparing SMILE with FS-LASIK postoperative biomechanical properties had varying results. Some studies indicated that biomechanical properties like corneal hysteresis (CH) and the corneal resistance factor (CRF) had greater reduction after FS-LASIK (Wu & Wang 2015; Osman et al. 2016 ). Other studies showed that there was no difference comparing SMILE with FS-LASIK postoperative corneal biomechanical properties Sefat et al. 2016) . One study by Wei et al. found that optical zone diameter has effects on corneal biomechanical properties after SMILE. The smaller optical zone diameter has a relatively smaller effect on CH and CRF (Wei et al. 2017) . A relatively low level of regression after SMILE extreme myopia correction found in this study could benefit from lesser biomechanical properties reduction after SMILE and/or a smaller optical zone, and long-term follow-up should be conducted in further studies. In conclusion, our results indicated that SMILE for treating extreme myopia and myopic astigmatism is feasible which had similar visual and refractive outcomes compared with conventional SMILE procedure during our 6 months observation period.
Regarding corneal stability, we used Scheimpflug imaging elevation data. Our results suggested that the postoperative posterior corneal surface remains stable if compared to preoperative data. In addition, we did not observe any change of the anterior and posterior corneal surfaces between postoperative 1 day and 6 months after SMILE. Previous studies also showed that the posterior corneal surface remained stable after SMILE for myopic correction up to À10 D at 12 months postoperatively (Gyldenkerne et al. 2015; Wang et al. 2016; Zhao et al. 2016) . Our results proved that cornea remained stable 6 months after SMILE for treating extreme myopia and myopic astigmatism. Comparing postoperative 6 months with preoperative wavefront aberration, HOA RMS, spherical aberration and coma increased significantly, but trefoil did not increase. Previous studies have found increase in HOA RMS and coma, but stable of spherical aberration and trefoil after SMILE (Shah et al. 2011; Yao et al. 2013; Agca et al. 2014; Tan et al. 2015; Wu & Wang 2016) , these results are consistent with ours except for spherical aberration. The reason for spherical aberration increase might possibly due to the relatively smaller optical zone to keep residual bed thickness in a safe range and higher level correction. Previous PRK and LASIK studies also indicated that optical zone had a significant impact on HOA (Roberts & Koester 1993; Freedman et al. 2003; Buhren et al. 2005; Mok & Lee 2005) . Further study should be conducted to explain the spherical aberration increase after SMILE for high myopia correction and its potential influence on visual quality such as contrast sensitivity and intra-ocular scattering.
Our study has several limitations. Most important, the number of eyes treated is small and the follow-up period of 6 months is too short to allow for any conclusions regarding corneal ectasia. Another limitation is that we did not assess optical quality by measuring contrast sensitivity and intra-ocular scattering. Small-incision lenticule extraction (SMILE) can be theoretically a justifiable surgery for high myopia in terms of induced HOAs. We already know that LASIK with high-level correction can lead to increased HOAs while less induction of HOAs has been found in SMILE (Vestergaard et al. 2013; Gyldenkerne Fig. 5 . Percentage of eyes attaining specified differences in attempted versus achieved correction at 6 months. SEQ, spherical equivalent. Fig. 6 . Stability of manifest spherical equivalent after small-incision lenticule extraction over the 6-month follow-up period. SEQ, spherical equivalent. CCT = central corneal thickness. D = dioptres, KMB = mean corneal back curvature (from central 4 mm diameter cornea), KMF = mean corneal front curvature (from central 4 mm diameter cornea), P = comparing with preoperative data, P 0 = comparing with postoperative 1 day data, PCE = posterior central elevation, DPCE = subtracting preoperative PCE from postoperative PCE. Liu et al. 2016) . Nevertheless, a more pronounced flattening of the cornea will inevitably induce more spherical aberration. This issue will be addressed in further studies.
In conclusion, our early results indicate that SMILE is safe, effective and reasonably predictable in the correction of very high myopia and myopic astigmatism up to À12 D without biomechanical problems. HOA RMS = root-mean-square of total higher-order aberration, P = comparing with preoperative data, P 0 = comparing with postoperative 3 month data, SD = standard deviation.
